Production (Stage)
Chemomab Therapeutics Ltd.
CMMB
$1.23
$0.032.50%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 14.27M | 12.73M | 15.88M | 19.78M | 32.71M |
| Total Receivables | 263.00K | 654.00K | 885.00K | 289.00K | 995.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.44M | -- | -- | 748.00K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 76.00K | 74.00K | 75.00K | 76.00K | 77.00K |
| Total Current Assets | 16.04M | 13.46M | 16.84M | 20.90M | 33.78M |
|
|
|||||
| Total Current Assets | 16.04M | 13.46M | 16.84M | 20.90M | 33.78M |
| Net Property, Plant & Equipment | 539.00K | 617.00K | 656.00K | 695.00K | 545.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 385.00K | 472.00K | 516.00K | 559.00K | 690.00K |
| Total Assets | 16.96M | 14.54M | 18.01M | 22.15M | 35.01M |
|
|
|||||
| Total Accounts Payable | 666.00K | 1.11M | 527.00K | 516.00K | 2.22M |
| Total Accrued Expenses | 2.44M | 3.09M | 3.76M | 4.25M | 4.67M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 115.00K | 109.00K | 110.00K | 76.00K | 115.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.22M | 4.31M | 4.40M | 4.84M | 7.00M |
|
|
|||||
| Total Current Liabilities | 3.22M | 4.31M | 4.40M | 4.84M | 7.00M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 209.00K | 251.00K | 280.00K | 316.00K | 62.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.43M | 4.56M | 4.68M | 5.15M | 7.06M |
|
|
|||||
| Common Stock & APIC | 116.16M | 106.16M | 105.88M | 105.68M | 101.74M |
| Retained Earnings | -102.62M | -96.18M | -92.55M | -88.68M | -72.57M |
| Treasury Stock & Other | -- | -- | -- | -- | -1.22M |
| Total Common Equity | 13.54M | 9.99M | 13.33M | 17.00M | 27.95M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.54M | 9.99M | 13.33M | 17.00M | 27.95M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 13.54M | 9.99M | 13.33M | 17.00M | 27.95M |
|
|
|||||